Raymond James & Associates’s eHealth EHTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-32,856
Closed -$838K 4158
2021
Q4
$838K Buy
+32,856
New +$1.09M ﹤0.01% 2735
2021
Q3
Sell
-6,374
Closed -$372K 4163
2021
Q2
$372K Sell
6,374
-11,170
-64% -$734K ﹤0.01% 3287
2021
Q1
$1.28M Sell
17,544
-43,795
-71% -$2.8M ﹤0.01% 2333
2020
Q4
$4.33M Buy
61,339
+3,342
+6% +$254K ﹤0.01% 1419
2020
Q3
$4.58M Sell
57,997
-8,919
-13% -$723K 0.01% 1279
2020
Q2
$6.57M Buy
66,916
+13,904
+26% +$1.62M 0.01% 1034
2020
Q1
$7.46M Sell
53,012
-3,511
-6% -$403K 0.01% 857
2019
Q4
$5.43M Buy
56,523
+38,544
+214% +$2.99M 0.01% 1194
2019
Q3
$1.2M Buy
17,979
+6,388
+55% +$576K ﹤0.01% 2084
2019
Q2
$998K Buy
11,591
+7,853
+210% +$528K ﹤0.01% 2218
2019
Q1
$233K Sell
3,738
-8,409
-69% -$463K ﹤0.01% 3135
2018
Q4
$467K Buy
12,147
+4,944
+69% +$166K ﹤0.01% 2591
2018
Q3
$204K Buy
+7,203
New +$191K ﹤0.01% 3281

Other funds holding EHTH

Raymond James & Associates's EHTH Position: Q1 2022 in Review

Raymond James & Associates sold out of eHealth (EHTH) in Q1 2022, closing a stake of 32,856 shares — an estimated $838K sold.

Raymond James & Associates first reported a position in EHTH in Q3 2018 and held it in 13 quarters. The position peaked at $7.46M in Q1 2020. 160 funds tracked by Wall St. Rank hold EHTH as of Q1 2022.

  • Raymond James & Associates reported no remaining eHealth position as of Q1 2022 after selling out during the quarter.
  • Raymond James & Associates sold 32,856 eHealth shares in Q1 2022, an estimated $838K.
  • Raymond James & Associates first reported a position in eHealth in Q3 2018 and held it in 13 quarters.
  • Raymond James & Associates's eHealth position peaked at $7.46M in Q1 2020.
  • 160 funds tracked by Wall St. Rank held eHealth as of Q1 2022.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.